BioCentury
ARTICLE | Emerging Company Profile

cellvie: Reviving cell metabolism via mitochondrial transplant

Harvard spinout using mitochondrial transfer to treat ischemia-reperfusion injury after kidney transplant

September 25, 2021 2:28 AM UTC

Harvard spinout cellvie is pioneering therapeutic mitochondria transplantation as a way to rescue cell energy metabolism and save cells that would otherwise die.

James McCully, a cellvie Inc. co-founder, developed the approach at Harvard Medical School to ameliorate ischemia-reperfusion injury, which is the tissue damage caused when blood supply returns after a period of ischemia...